Showing results (1-10 of 747) with videos related to
Sort By:
Pageof 75
The Journal of Pharmacy and Pharmacology|December 1, 1991
A novel bradykinin antagonist with improved propertiesB Lammek, Y X Wang, I Gavras, et al.Peptides|September 1, 1990
A new highly potent antagonist of bradykininB Lammek, Y X Wang, I Gavras, et al.Journal of Hypertension|September 1, 1991
Effects of bradykinin and prostaglandin inhibition on systemic and regional hemodynamics in conscious normotensive ratsY X Wang, I Gavras, B Lammek, et al.The Journal of Pharmacy and Pharmacology|January 1, 1991
Two highly effective V1/V2 antagonists of vasopressin containing novel thioacids at position 1B Lammek, Y X Wang, R Franco, et al.Hypertension (Dallas, Tex. : 1979)|February 1, 1992
Inhibition of nitric oxide, bradykinin, and prostaglandins in normal ratsY X Wang, I Gavras, T Wierzba, et al.The Journal of Laboratory and Clinical Medicine|March 1, 1992
Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive ratsY X Wang, I Gavras, T Wierzba, et al.The Journal of Laboratory and Clinical Medicine|April 1, 1991
Effects of chronic administration of a vasopressin antagonist with combined antivasopressor and antiantidiuretic activities in rats with left ventricular dysfunctionY X Wang, R Franco, I Gavras, et al.Polish Journal of Pharmacology and Pharmacy|March 1, 1992
Synthesis and some pharmacological properties of new V1/V2 antagonists of arginine-vasopressin with structural changes at their N-terminalsB Lammek, E Konieczna, T Wierzba, et al.Peptides|September 1, 1989
Synthesis and some pharmacologic properties of five novel V1 or V1/V2 antagonists of AVPB Lammek, Y X Wang, I Derdowska, et al.Circulation|January 1, 1990
Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunctionR A Mulinari, I Gavras, Y X Wang, et al.Pageof 75